Cancer diagnostic firm Caris Life Sciences on Monday raised the proposed price range for its New York initial public offering, targeting a valuation of up to $5.67 billion and indicating a strong ...

When Marais approaches the unconscious rhino, he covers its eyes to protect them and then uses a chainsaw to cut off its ...

Two-thirds of its members rely on Chime as the primary financial relationship. Through its platform, members deposit their ...